You have 9 free searches left this month | for more free features.

City

Murdoch (2)

Condition

Urothelial Carcinoma (2)

Bladder Cancer (1)

Clear Cell Renal Cell Carcinoma (1)

Recurrent Renal Cell Cancer (1)

Suspected Recurrent Renal Clear Cell Carcinoma (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 1/phase 2 (1)

Sponsor

Telix International Pty Ltd (2)

South Metropolitan Health Service (1)

Collaborator

Grand Pharmaceutical (China) Co., Ltd. (1)

Telix International Pty Ltd (1)

Intervention

89zr-girentuximab (3)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

89zr-girentuximab

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

Not yet recruiting

Clear Cell Renal Cell Carcinoma
+2 more

89Zr-Girentuximab

(no location specified)

May 14, 2023

Urothelial Carcinoma Trial in Murdoch (89Zr-Girentuximab)

Recruiting

Urothelial Carcinoma
Bladder Cancer

89Zr-Girentuximab

Murdoch, Western Australia, Australia

Fiona Stanley Hospital

Aug 22, 2021

Urothelial Carcinoma Trial in Murdoch (89Zr-Girentuximab)

Recruiting

Urothelial Carcinoma

89Zr-Girentuximab

Murdoch, Western Australia, Australia

Fiona Stanley Hospital

Sep 8, 2021